-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $130

Benzinga·11/16/2026 15:55:11
Listen to the news
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.